Clinical Trial Update: Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in Bangladesh [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in Bangladesh evaluating azithromycin in combination therapy for uncomplicated Plasmodium falciparum malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Medical University of Vienna | Conditions: Uncomplicated Falciparum Malaria | Phase 2 | Status: COMPLETED